Impact of Mild or Moderate Renal Insufficiency on the Intravascular Ultrasonic Analysis of Chronic Vascular Response to Paclitaxel-Eluting and Bare-Metal Stents (from the TAXUS IV, V, and VI Trials)

American Journal of Cardiology

Volumn 102, Issue 8, 2008, Pages 1009-1016

  Aoki, Jiro ^a   Mintz, Gary S ^a   Weissman, Neil J ^b   Mandinov, Lazar ^c   Grube, Eberhard ^d   Dawkins, Keith D ^e   Ellis, Stephen G ^f   Greenberg, Joel ^g   Yu, Alan ^c   Mann, J Tift ^h   Cannon, Louis ⁱ   Cambier, Patrick A ^j   Stone, Gregg W ^a  

^a Department of Medicine   (United States)

^b Washington Hospital Center   (Colombia)

^c BOSTON SCIENTIFIC CORPORATION   (United States)

^d Helios Klinikum   (Germany)

^e UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^f LERNER RESEARCH INSTITUTE   (United States)

^g Florida Heart Institute   (United States)

^h Wake Heart Center   (United States)

ⁱ Cardiac and Vascular Research Center of Northern Michigan   (United States)

^j Heart and Vascular Institute of Florida   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; PACLITAXEL;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; BARE METAL STENT; CORONARY STENT; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG ELUTING STENT; FEMALE; HUMAN; INTRAVASCULAR ULTRASOUND; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY CIRCULATION; CORONARY DISEASE; CREATININE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METALS; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; SEVERITY OF ILLNESS INDEX; STENTS; TIME FACTORS; TREATMENT OUTCOME; TUBULIN MODULATORS; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR RESISTANCE;

EID: 54549116168     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.05.051     Document Type: Article

References (30)

1. Gruberg L., Weissman N.J., Waksman R., Laird Jr. J.R., Pinnow E.E., Wu H., Deible R., Kent K.M., Pichard A.D., Satler L.F., and Lindsay Jr. J. Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild chronic renal insufficiency. Am J Cardiol 89 (2002) 54-57
2. Blackman D.J., Pinto R., Ross J.R., Seidelin P.H., Ing D., Jackevicius C., Mackie K., Chan C., and Dzavik V. Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention. Am Heart J 151 (2006) 146-152
3. Best P.J., Lennon R., Ting H.H., Bell M.R., Rihal C.S., Holmes D.R., and Berger P.B. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39 (2002) 1113-1119
4. Gruberg L., Dangas G., Mehran R., Mintz G.S., Kent K.M., Pichard A.D., Satler L.F., Lansky A.J., Stone G.W., and Leon M.B. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv 55 (2002) 66-72
5. Pinkau T., Mann J.F., Ndrepepa G., Mehilli J., Hadamitzky M., Braun S., Kastrati A., and Schomig A. Coronary revascularization in patients with renal insufficiency: restenosis rate and cardiovascular outcomes. Am J Kidney Dis 44 (2004) 627-635
6. Aoki J., Ong A.T., Hoye A., van Herwerden L.A., Sousa J.E., Jatene A., Bonnier J.J., Schonberger J.P., Buller N., Bonser R., et al. Five year clinical effect of coronary stenting and coronary artery bypass grafting in renal insufficient patients with multivessel coronary artery disease: insights from ARTS trial. Eur Heart J 26 (2005) 1488-1493
7. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
8. Stone G.W., Ellis S.G., Cannon L., Mann J.T., Greenberg J.D., Spriggs D., O'Shaughnessy C.D., DeMaio S., Hall P., Popma J.J., et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 294 (2005) 1215-1223
9. Dawkins K.D., Grube E., Guagliumi G., Banning A.P., Zmudka K., Colombo A., Thuesen L., Hauptman K., Marco J., Wijns W., et al. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation 112 (2005) 3306-3313
10. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
11. Mosteller R.D. Simplified calculation of body-surface area. N Engl J Med 317 (1987) 1098
12. Mintz G.S., Nissen S.E., Anderson W.D., Bailey S.R., Erbel R., Fitzgerald P.J., Pinto F.J., Rosenfield K., Siegel R.J., Tuzcu E.M., and Yock P.G. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 37 (2001) 1478-1492
13. Mintz G.S., Hong M.K., Raizner A.E., Lee C.W., Kim J.J., Escolar E., Fearnot N.E., Park S.W., Park S.J., and Weissman N.J. Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents. Am J Cardiol 95 (2005) 107-109
14. Mintz G.S., Tinana A., Hong M.K., Lee C.W., Kim J.J., Fearnot N.E., Park S.W., Park S.J., and Weissman N.J. Impact of preinterventional arterial remodeling on neointimal hyperplasia after implantation of (non-polymer-encapsulated) paclitaxel-coated stents: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Circulation 108 (2003) 1295-1298
15. Aoki J., Colombo A., Dudek D., Banning A.P., Drzewiecki J., Zmudka K., Schiele F., Russell M.E., Koglin J., and Serruys P.W. Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study. Circulation 112 (2005) 3876-3883
16. Kaysen G.A., and Eiserich J.P. The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction. J Am Soc Nephrol 15 (2004) 538-548
17. Endemann D.H., and Schiffrin E.L. Endothelial dysfunction. J Am Soc Nephrol 15 (2004) 1983-1992
18. Han S.H., Quon M.J., Kim J.A., and Koh K.K. Adiponectin and cardiovascular disease: response to therapeutic interventions. J Am Coll Cardiol 49 (2007) 531-538
19. Schiffrin E.L., Lipman M.L., and Mann J.F. Chronic kidney disease: effects on the cardiovascular system. Circulation 116 (2007) 85-97
20. Gruberg L., Rai P., Mintz G.S., Canos D., Pinnow E., Satler L.F., Pichard A.D., Kent K.M., Waksman R., Lindsay J., and Weissman N.J. Impact of renal function on coronary plaque morphology and morphometry in patients with chronic renal insufficiency as determined by intravascular ultrasound volumetric analysis. Am J Cardiol 96 (2005) 892-896
21. 2: a meta-analysis of intravascular ultrasound studies. Am J Cardiol 99 (2007) 813-816
22. Rowinsky E.K., and Donehower R.C. Paclitaxel (Taxol). N Engl J Med 332 (1995) 1004-1014
23. Kamath K.R., Barry J.J., and Miller K.M. The Taxus drug-eluting stent: a new paradigm in controlled drug delivery. Adv Drug Deliv Rev 58 (2006) 412-436
24. Tanabe K., Serruys P.W., Degertekin M., Guagliumi G., Grube E., Chan C., Munzel T., Belardi J., Ruzyllo W., Bilodeau L., et al. Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial. Circulation 109 (2004) 196-200
25. Weissman N.J., Koglin J., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., et al. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. J Am Coll Cardiol 45 (2005) 1201-1205
26. Aoki J., Abizaid A., Ong A.T., Tsuchida K., and Serruys P. Serial assessment of tissue growth inside and outside the stent after implantation of drug-eluting stent in clinical trials. Does delayed neointimal growth exist?. Eurointervention 1 (2005) 253-255
27. Mintz G.S., Shah V.M., and Weissman N.J. Regional remodeling as the cause of late stent malapposition. Circulation 107 (2003) 2660-2663
28. Tanabe K., Serruys P.W., Degertekin M., Grube E., Guagliumi G., Urbaszek W., Bonnier J., Lablanche J.M., Siminiak T., Nordrehaug J., et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation 111 (2005) 900-905
29. Ako J., Morino Y., Honda Y., Hassan A., Sonoda S., Yock P.G., Leon M.B., Moses J.W., Bonneau H.N., and Fitzgerald P.J. Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol 46 (2005) 1002-1005
30. Hong M.K., Mintz G.S., Lee C.W., Park D.W., Park K.M., Lee B.K., Kim Y.H., Song J.M., Han K.H., Kang D.H., et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 113 (2006) 414-419